Effectiveness of clozapine in hospitalised people with chronic neuroleptic-resistant schizophrenia

M. Avnon, J. Rabinowitz

Research output: Contribution to journalArticlepeer-review

22 Scopus citations


Background. Clozapine's effectiveness in reducing symptoms and facilitating discharge among patients with chronic schizophrenia who were resistant to neuroleptics was studied. Method. All 169 such patients in a public psychiatric hospital were given clozapine. BPRS ratings (0-5 scale) were completed before treatment and 21 months later. Patients were followed for about 2.5 years. Results. Clozapine was discontinued in 37.8% of cases due to non-compliance, non-response, or side-effects. At follow-up 41% of clozapine recipients and 25.9% of the drop-outs were discharged and remained so, and 33% of recipients and 24.1% of drop-outs were being prepared for discharge. Longer treatment was associated with more improvement. Decline in average BPRS total scores of recipients was significantly more than drop- outs (32.7, s.d. 16.8 v. 12.1, s.d. 14.1, d.f. = 155, t = 7.5, P=0.000). Conclusions. Clozapine appears to be effective for treating some chronic neuroleptic non-responding schizophrenic patients.

Original languageEnglish
Pages (from-to)760-764
Number of pages5
JournalBritish Journal of Psychiatry
Issue numberDEC.
StatePublished - 1995


Dive into the research topics of 'Effectiveness of clozapine in hospitalised people with chronic neuroleptic-resistant schizophrenia'. Together they form a unique fingerprint.

Cite this